Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Limtop dosing regimen study in actinic keratosis of the head
2011-004538-32Phase 2Completed
- Sponsor
- Moberg Pharma AB
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Limtop in actinic keratosis (AK) (4 arms), sponsored by Moberg Pharma AB. Primary endpoint: Primary efficacy variable. Started Dec 2011; status: completed.
02
Drugs
Limtop
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2011-004538-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004538-32.